Kwayar cutar ta HPV tana yawan faruwa a cikin mutane masu yin jima'i, amma kamuwa da cuta na ci gaba yana tasowa ne kawai a cikin ƙaramin adadin lokuta. Dagewar HPV ya haɗa da haɗarin haɓaka cututtukan mahaifa da kuma, a ƙarshe, kansar mahaifa.
Ba za a iya al'adar HPVs bain vitrota hanyoyin al'ada, da kuma faffadan bambance-bambancen dabi'a na amsawar rigakafi na ban dariya bayan kamuwa da cuta yana lalata amfani da takamaiman gwajin rigakafin cutar HPV a cikin ganewar asali. Don haka ana samun gano cutar ta HPV ta hanyar gwajin kwayoyin halitta, musamman ta hanyar gano kwayar halittar HPV DNA.
A halin yanzu, akwai nau'ikan hanyoyin kasuwanci na HPV na genotyping. Zaɓin wanda ya fi dacewa ya dogara da abin da aka yi niyyar amfani da shi, watau: ilimin cututtuka, kimantawar rigakafin, ko nazarin asibiti.
Don nazarin cututtukan cututtuka, hanyoyin HPV genotyping suna ba da damar zana takamaiman nau'in yaduwa.
Don kimantawar rigakafin, waɗannan gwaje-gwajen suna ba da bayanai game da canje-canjen yaduwa ga nau'ikan HPV waɗanda ba a haɗa su cikin alluran rigakafi na yanzu ba, kuma suna sauƙaƙe bibiyar cututtukan da suka ci gaba.
Don karatun asibiti, jagororin ƙasashen duniya na yanzu suna ba da shawarar yin amfani da gwajin genotyping na HPV tsakanin mata masu shekaru 30 da haihuwa tare da cytology mara kyau da ingantaccen sakamako na HPV na HR, a cikin HPV-16 da HPV-18 na musamman. Gano HPV da nuna wariya ga manya- da ƙananan haɗari genotypes sau biyu ko fiye don nemo marasa lafiya tare da cututtukan cututtuka iri ɗaya na genotype, yana haifar da ingantacciyar kulawar asibiti.
Macro & Micro-Gwajin HPV na'urorin sarrafa kwayoyin halitta:
- Nau'in HPV guda 14 (Genotyping) Kit ɗin Gano Acid Nucleic (Fluorescence PCR)
- Daskare-busassun nau'ikan HPV guda 14 (Genotyping) Kit ɗin Gano Acid Nucleic (Fluorescence PCR)
- 28 Nau'in HPV (Genotyping) Kayan Ganewa (Fluorescence PCR) (18 HR-HPVs +10 LR-HPVs)
- Daskare-bushe Nau'in HPV 28 (Genotyping) Kayan Ganewa (Fluorescence PCR)
Mahimman abubuwan samfur:
- Gano lokaci guda na genotypes da yawa a cikin amsa ɗaya;
- Shortan gajeren lokacin juyawa na PCR don yanke shawara na asibiti cikin sauri;
- Ƙarin nau'ikan samfurin (fitsari/swab) don ƙarin jin daɗi da samun damar gwajin kamuwa da cutar ta HPV;
- Dual Internal Controls yana hana ingancin karya kuma yana tabbatar da amincin gwaji;
- Liquid da nau'ikan lyophilized don zaɓuɓɓukan abokan ciniki;
- Daidaituwa tare da yawancin tsarin PCR don ƙarin daidaitawar lab.

Lokacin aikawa: Juni-04-2024